Leerink Partners analyst Richard Newitter reiterated an Outperform rating and $31 price target on Wright Medical (NASDAQ: WMGI), saying Augment ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments FDA

Northland Capital Markets Remains Bullish on Wright Medical Group (WMGI) Following AUGMENT FDA Approval September 2, 2015 9:40 AM Augment Approval Provides Catalyst for Wright Medical (WMGI), Brean Capital SaysSeptember 2, 2015 7:26 AM Wright Medical Group (WMGI) Reports FDA Approval of AUGMENT Bone GraftSeptember 1, 2015 4:13 PM Wright Medical Group, Inc. Announces FDA Approval for AUGMENT(R) Bone GraftSeptember 1, 2015 4:00 PM